Rosuvastatin with Ongoing Care
Rosuvastatin reduces cholesterol production in the liver and lowers LDL cholesterol. It has evidence for cardiovascular risk reduction and slowing atherosclerosis progression in eligible patients. Your clinician selects a dose based on your risk, kidney function, other medications, and response to treatment. Available through Healthspan Membership with clinician-led evaluation and ongoing care. Your clinician determines whether this treatment is appropriate; a prescription is not guaranteed.
Care through Healthspan Membership
Membership is $99 per month, billed $297 every three months. Receive biomarker testing through your membership, care-team guidance, and access to prescription evaluation for cholesterol management. Your clinician reviews your history and results to determine which treatment, if any, is appropriate.